The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia

Saudi Medical Journal

Volumn 25, Issue 2, 2004, Pages 207-211

  Abdel Gayoum, Abdel Gayoum A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; GLUCOSE; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CLINICAL LABORATORY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY DIAGNOSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CODING; PATIENT SELECTION; REGRESSION ANALYSIS; RISK ASSESSMENT; SAUDI ARABIA; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FRUCTOSAMINE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SAUDI ARABIA;

EID: 1442326783     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Grant RW, Caqliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB. Comparison of hyperglycemia and hypercholesterolemia in patients with type 2 DM. Am J Med 2002; 112: 603-609.
2. Sanz Paris A, Sancho Serrano MA, Albero Gamboa R. Lipid metabolism and new diabetic recommendations in DM. An Med Interna 1996; 13: 136-145.
3. Stehbens WE. The epidemiological relationship of hypercholesterolemia, hypertension, DM and obesity to coronary heart disease and atherogenesis. J Clin Epidemiol 1990; 43: 733-741.
4. Fuller CJ, Chanadalia M, Garg A, Grundy SM, Jialal I. RRR-alpha tocopheryl acetate at pharmacologic doses decreases low density lipoprotein oxidative susceptibility but not protein glycation in patients with DM. Am J Clin Nutr 1996; 63: 753-759.
5. Akanji AO, Abdella N, Mojiminivi OA. Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidemic patients in Kuwait. Clin Chim Acta 2002; 317: 171-176.
6. Vinci VS, Masotti G, Citro G, De Marca S, Quaglla C, Galasso R. Importance of the determination of fructosamine in monitoring diabetic patients. Medicina (Firenze) 1990; 10: 25-27.
7. Rahman AA. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years. Int J Cardiol 1997; 62: 227-235.
8. Harris MI. Hypercholesterolemia in diabetes and glucose intolerance in the US population. Diabetes Care 1991; 4: 366-374.
9. Wolever TM, Jenkins DJ, Vuksan V, Jenkins AL, Buckley GC, Wong GS, et al. Beneficial effect of a low glycemic index diet in type 2 diabetes. Diabet Med 1992; 9: 451-458.
10. Bor MV, Bor P, Ceyik C. Serum fructosamine and fructosamine-albumin ratio as screening tests for gestational DM. Arch Gynecol Obstet 1999; 262: 105-111.
11. Lim TO, Selvan T, Suppiah A, Khan N, Ismail F. Comparison of serum fructosamine and blood glucose concentrations as indices of glycaemic control in non-insulin dependent diabetic out-patients. Singapore Med J 1992; 33: 287-289.
12. Keller U, Golay A, Pometta D. Dyslipidemia in DM: significance, diagnosis and treatment. Schweiz Rundsch Med Prax 1990; 79: 199-204.
13. Akbar DH. Is hypertension common in hospitalized type 2 diabetic patients? Saudi Med J 2001; 22: 139-141.
14. Alam SM, Ali S, Khalil M, Deb K, Ahmed A, Akhter K. Serum lipid profile in hypertensive type II DM patients: A comparative study. Mymensingh Med J 2003; 12: 13-16.
15. Grundy SM, Vega GL, Kesaniemi YA. Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease. Acta Med Scand Suppl 1985; 701: 23-37.
16. Schlondorff D. Cellular mechanism of lipid injury in the glomerulus Am J Kid Dis 1993; 22: 72-82.
17. Cosentino F, Luscher TF. Endothelial dysfunction in DM. J Cardiovasc Pharmacol 1998; 32: S55-S61.
18. Makita T, Tanaka A, Nakano T, Nakajima K, Numano F. Importance of glycation in the acceleration of low density lipoprotein (LDL) uptake into macrophages in patients with DM. Int Angiol 1999; 18: 149-153.
19. Moro E, Alessandrini P, Zambon C, Pianetti S, Pais M, Cazzolato G et al. Is glycation of low density lipoprotein in patients with type 2 DM a LDL pre-oxidative condition? Diabet Med 1999; 16: 663-669.
20. Reaven PD, Herold DA, Barnett J, Edelman S. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 1995; 18: 807-816.
21. Kondo A, Muranaka Y, Ohta K, Manabe M, Kotani K, Saito K et al. Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL. Clin Chem 2001; 47: 893-900.
22. Guerin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL (1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vas Biol 2001; 21: 282-288.
23. Klein RL, Laimins M, Lopes-Virella MF. Isolation, characterization and metabolism of the glycated and non-glycated subfractions of low density lipoproteins isolated from type 1 diabetic patients and non diabetic subjects. Diabetes 1995; 44: 1093-1098.